A61K 31/4462
Only substituted in position 3
Official title: only substituted in position 3
A61K31/4462 (Only substituted in position 3) appears on 32 US grants and 54 published applications in this corpus.
Search patents in A61K- Granted patents
- 32
- Published applications
- 54
- Assignees
- 52
- Inventors
- 165
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 3 |
| 2005 | 1 | 1 |
| 2006 | 1 | 2 |
| 2007 | 1 | 1 |
| 2008 | 1 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 3 | 3 |
| 2014 | 1 | 2 |
| 2015 | 0 | 1 |
| 2016 | 0 | 3 |
| 2017 | 2 | 4 |
| 2018 | 0 | 3 |
| 2019 | 2 | 3 |
| 2020 | 1 | 5 |
| 2021 | 3 | 4 |
| 2022 | 3 | 4 |
| 2023 | 1 | 2 |
| 2024 | 1 | 4 |
| 2025 | 2 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Prevention or treatment of chronic organ injury14 Oct 2025US 12,440,479 B2Board of Regents, The University of Texas System
- Treatment of mitochondrial diseases18 Feb 2025US 12,226,394 B2Khondrion IP B.V.
- Subcutaneous delivery of polymer conjugates of therapeutic agents2 Apr 2024US 11,944,618 B2Serina Therapeutics, Inc.
- CHK1 (SRA737)/PARPi combination methods of inhibiting tumor growth7 Mar 2023US 11,596,637 B2Sierra Oncology, Inc.
- Subcutaneous delivery of polymer conjugates of therapeutics agents12 Apr 2022US 11,298,350 B2Serina Therapeutics, Inc.
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
- Targeting Cells with a Combination of CXCR2 Inhibition and CD47 Blockade11 Dec 2025US 2025/0376522 A1
- Treatment of mitochondrial diseases28 Nov 2024US 2024/0390321 A1Khondrion IP B.V.
- Compounds for use in progressive multiple sclerosis9 May 2024US 2024/0148745 A1Assistance Publique-Hopitaux de Paris
- Kinase inhibitors and uses thereof14 Mar 2024US 2024/0083844 A1ABM Therapeutics Corporation
Most cited
By later US patents
- Small molecule toll-like receptor (TLR) antagonists91US 7,410,975 B2Coley Pharmaceutical GmbH · 2008
- Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases45US 6,071,970 ANPS Pharmaceuticals, Inc. · 2000
- N-acyl anthranilic acid derivative or salt thereof32US 8,492,582 B2Toyama Chemical Co., Ltd. · 2013
- Subcutaneous delivery of poly(oxazoline) conjugates15US 8,383,093 B1Serina Therapeutics, Inc. · 2013
- Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases8US 6,017,965 ANPS Pharmaceuticals, Inc. · 2000